Primary signet cell carcinoma of the prostate: a case report

Sungur M., Senturk A. B., Caliskan S., Gurel A.

MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, vol.10, no.2, pp.115-117, 2017 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 10 Issue: 2
  • Publication Date: 2017
  • Doi Number: 10.1007/s12254-017-0327-3
  • Journal Name: MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
  • Page Numbers: pp.115-117
  • Yozgat Bozok University Affiliated: Yes

Abstract

Primary signet cell carcinoma of the prostate is very rare histological variant and usually originates from the stomach, colon, and pancreas. This malignancy was first reported in 1979 and there have been case series with small numbers of patients and case reports in the literature. Signet cell carcinoma of the prostate has a poor outcome when compared to classic prostate adenocarcinoma. A case of primary signet cell carcinoma of the prostate that was treated with maximal androgen deprivation therapy with zoledronic acid is reported.